X.T.L. Biopharmaceuticals Ltd. XTLB
NAS: XTLB | ISIN: US98386D3070 1/05/2025
1,530 USD (+8,51%)
(+8,51%)
1/05/2025
Profiel X.T.L. Biopharmaceuticals Ltd.
Website: www.xtlbio.com
Hoofdzetel: New York, New York Verenigde Staten
CEO: Joshua Levine
Werknemers: 1